title: [Cellular mechanisms of tumor response: clinical demands].
abstract: Diseases caused by cancer have become more common due to an increase in life-expectation, but the probability of reaching an old age with or without a tumor disease is still increasing. According to the statistics of the German Cancer register, at present more than half of cancer patients survive for at least 5 years after cancer has been diagnosed. Many tumors can be cured using innovative neoadjuvant and adjuvant therapy regimes, but the options for palliative therapy have also been improved. This leads to an increasing importance of the evaluation of the tumor response using imaging techniques. Classically, tumor response is measured by imaging using the RECIST (response evaluation criteria in solid tumors) criteria, which define the changes in size of the tumor during therapy. However, there is increasingly more evidence that RECIST as the only measure of tumor response, does not document tumor response for all tumor entities and especially not for many medications known as targeted therapy. This article gives a review of the principles and mode of effect of various therapy regimes as well as the clinical demands on imaging techniques.
authors.affiliation: Abteilung für Radiologie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland.
authors.forename: M-K
authors.initials: MK
authors.lastname: Ganten
authors.forename: M A
authors.initials: MA
authors.lastname: Weber
authors.forename: T M
authors.initials: TM
authors.lastname: Ganten